Awak PD - Portable Dialysis System

Main article: Dialysis

2023: Attracting investment for further testing

Awak Technologies has developed a dialysis machine that is so small that it can fit into a shoulder bag for on-the-go treatments. This was EverCare.ru announced by Zdrav.Expert on October 9, 2023.

𝓲

evercare.ru

Recently, this the Singapore company raised $20 million as part of another round of funding from the group. venture capital investors In total, Awak Technologies has already received more than 80 million from venture capital funds. dollars USA

The additional funds will help Awak complete preliminary trials started in June at Singapore General Hospital, as well as arrange further technological developments that will be deemed necessary in line with the results of the study. After all these tasks have been resolved, the company plans to begin a preliminary trial in the United States in 2025 in order to subsequently apply for approval for use from US regulators and other countries.

Awak technology allows peritonal dialysis procedures, which are performed daily and are based on the use of the patient's peritoneum as a membrane filter. Dialysis fluid is delivered into abdominal cavity through surgically installed catheter. This differs from the more common hemodialysis, which is usually done three to five days a week and requires the removal and purification of the patient's blood in a separate apparatus before returning to the body.

𝓲

evercare.ru

The Awak PD can be used almost anywhere, as it fits into a small shoulder bag. Users can control the device using a connected mobile application, which also automatically transmits information about the user's treatment to his doctors for remote control.

The small size of the device is due to the fact that it requires only a few liters of dialysis fluid per day, while other similar systems require 10-12 liters. The fact is that Awak has developed technology to remove toxins from used dialysate, automatically recycling it for reuse throughout the day.

The super-portable dialysis machine has already received support from the US health industry regulator (FDA). In 2019, the agency awarded this technology the status of a "breakthrough device," which speeds up the consideration of any future regulatory applications.

In addition to supporting AWAK PD's current and future developments, the company said it plans to use the funding it has received to expand its kidney care technology portfolio. These may include both physical and digital products that will make home dialysis more accessible and alleviate the patient burden associated with this^[1].

Notes